Leading source of Financial News, Investor Forums, CEO Interviews, Financial Columnists, Stock Information

Add to MyProactive

Kazia Therapeutics Ltd - Kazia Therapeutics Phase II Paxalisib glioblastoma study shows positive overall survival data

Kazia Therapeutics Phase II Paxalisib glioblastoma study shows positive overall survival signal data

6 hours, 58 minutes ago

CytoDyn Inc. - CytoDyn treats two coronavirus patients in Phase 2 trial

Full interview: CytoDyn treats two coronavirus patients in Phase 2 trial

17 hours, 3 minutes ago

OncoSec Medical Incorporated -

OncoSec Medical partnering with Providence Cancer Institute on CORVax12 trial for potential coronavirus vaccine

18 hours, 38 minutes ago

People wearing scrubs and stethoscopes, one points to tablet with a pen

TRACON earns May 8 date with FDA to discuss pivotal study of its drug envafolimab as a treatment for tissue cancer

20 hours, 57 minutes ago

GlaxoSmithKline PLC -

GlaxoSmithKline injects US$250mln into US biotech Vir in coronavirus treatment collaboration

21 hours, 5 minutes ago

CytoDyn Inc. -

CytoDyn enrolls two patients in Phase 2 coronavirus of leronlimab; 15 severely ill patients treated separately so far

21 hours, 27 minutes ago

Co-Diagnostics -- receives FDA Emergency Use Authorization for its coronavirus test

Co-Diagnostics receives FDA Emergency Use Authorization for its coronavirus test

22 hours, 2 minutes ago

Antibe Therapeutics Inc -

Echelon rates Antibe Therapeutics as 'top pick' as investors eagerly await Phase II data from ATB-346 study

3 days, 17 hours ago

CytoDyn Inc. - CytoDyn requests initial meeting with FDA for Breakthrough Therapy status for leronlimab in treating cancer

CytoDyn requests initial meeting with FDA for Breakthrough Therapy status for leronlimab in treating cancer

3 days, 22 hours ago

Avalon GloboCare Corp - Avalon GlobalCare Corp

Avalon GloboCare seeks to tap the power of cells to fight cancer

3 days, 23 hours ago

CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients

CytoDyn sees impressive results with Leronlimab on very ill COVID-19 patients

4 days, 16 hours ago

Algernon Pharmaceuticals updates Phase 2 human testing of Ifenprodil for COVID-19

Full interview: Algernon Pharmaceuticals updates Phase 2 human testing of Ifenprodil for COVID-19

4 days, 16 hours ago

Exactus, Inc. -

Exactus shares lifted as it unveils plans to expand partnership with Hemptown USA

4 days, 18 hours ago

Algernon Pharmaceuticals Inc. -

Algernon Pharmaceuticals finalizes protocol to launch Phase 2 trial of Ifenprodil for coronavirus patients

4 days, 20 hours ago

Pfizer -

ImmunoPrecise Antibodies names Yasmina Noubia Abdiche as chief scientific officer

4 days, 20 hours ago

Helix BioPharma Corp. - Helix BioPharma Corp moves to protect the health and well-being of staff while maintaining business continuity amid the coronavirus pandemic

Helix BioPharma maintaining business continuity amid coronavirus pandemic

4 days, 21 hours ago

Person using a ventilator

CytoDyn says coronavirus patients treated with leronlimab show initial improvements after three days

4 days, 21 hours ago

Humanigen, Inc. - Humanigen's lenzilumab gets FDA nod for emergency IND use on compassionate grounds in coronavirus patients

Humanigen's lenzilumab gets FDA nod for emergency use on compassionate grounds in coronavirus patients

4 days, 22 hours ago

Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in Japan

Full interview: Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in Japan

5 days, 14 hours ago

Acasti Pharma Inc -

Acasti Pharma shares nudge higher as it files meeting request with the US Food and Drug Administration

5 days, 19 hours ago